Dyax Corp (DYAX) – Hot FDA News
-
Dyax Corp (DYAX) Announces Positive Results from Phase 1b Trial of DX-2930 and Fast Track Designation
-
UPDATE: Dyax Corp. (DYAX) Slammed; to Discontinue Ecallantide Phase 2 Based on Results of Interim Analysis
Back to DYAX Stock Lookup